ALERS Statistics

Total Valuation

Eurobio Scientific Société anonyme has a market cap or net worth of EUR 259.13 million. The enterprise value is 265.94 million.

Market Cap	259.13M
Enterprise Value	265.94M

Important Dates

The next estimated earnings date is Tuesday, December 24, 2024.

Earnings Date	Dec 24, 2024
Ex-Dividend Date	n/a

Share Statistics

Eurobio Scientific Société anonyme has 10.04 million shares outstanding. The number of shares has increased by 8.96% in one year.

Current Share Class	n/a
Shares Outstanding	10.04M
Shares Change (YoY)	+8.96%
Shares Change (QoQ)	n/a
Owned by Insiders (%)	1.41%
Owned by Institutions (%)	7.62%
Float	1.90M

Valuation Ratios

The trailing PE ratio is 42.96 and the forward PE ratio is 29.32.

PE Ratio	42.96
Forward PE	29.32
PS Ratio	1.97
PB Ratio	1.45
P/TBV Ratio	n/a
P/FCF Ratio	12.98
P/OCF Ratio	n/a
PEG Ratio	n/a

Financial Ratio History

Enterprise Valuation

The stock's EV/EBITDA ratio is 12.89, with an EV/FCF ratio of 13.33.

EV / Earnings	40.03
EV / Sales	1.84
EV / EBITDA	12.89
EV / EBIT	20.62
EV / FCF	13.33

Financial Position

The company has a current ratio of 2.69, with a Debt / Equity ratio of 0.52.

Current Ratio	2.69
Quick Ratio	2.20
Debt / Equity	0.52
Debt / EBITDA	4.53
Debt / FCF	4.68
Interest Coverage	3.03

Financial Efficiency

Return on equity (ROE) is 3.75% and return on invested capital (ROIC) is 2.91%.

Return on Equity (ROE)	3.75%
Return on Assets (ROA)	2.57%
Return on Capital (ROIC)	2.91%
Revenue Per Employee	439,900
Profits Per Employee	20,191
Employee Count	300
Asset Turnover	0.46
Inventory Turnover	3.72

Taxes

Income Tax	n/a
Effective Tax Rate	n/a

Stock Price Statistics

The stock price has increased by +59.26% in the last 52 weeks. The beta is -0.26, so Eurobio Scientific Société anonyme's price volatility has been lower than the market average.

Beta (5Y)	-0.26
52-Week Price Change	+59.26%
50-Day Moving Average	25.55
200-Day Moving Average	19.38
Relative Strength Index (RSI)	54.55
Average Volume (20 Days)	27,711

Short Selling Information

Short Interest	n/a
Short Previous Month	n/a
Short % of Shares Out	n/a
Short % of Float	n/a
Short Ratio (days to cover)	n/a

Income Statement

In the last 12 months, Eurobio Scientific Société anonyme had revenue of EUR 144.73 million and earned 6.64 million in profits. Earnings per share was 0.60.

Revenue	144.73M
Gross Profit	66.83M
Operating Income	12.90M
Pretax Income	9.97M
Net Income	6.64M
EBITDA	20.63M
EBIT	12.90M
Earnings Per Share (EPS)	0.60

Full Income Statement

Balance Sheet

The company has 86.59 million in cash and 93.40 million in debt, giving a net cash position of -6.81 million or -0.68 per share.

Cash & Cash Equivalents	86.59M
Total Debt	93.40M
Net Cash	-6.81M
Net Cash Per Share	-0.68
Equity (Book Value)	178.83M
Book Value Per Share	17.83
Working Capital	92.13M

Full Balance Sheet

Cash Flow

In the last 12 months, operating cash flow was 23.07 million and capital expenditures -3.12 million, giving a free cash flow of 19.96 million.

Operating Cash Flow	23.07M
Capital Expenditures	-3.12M
Free Cash Flow	19.96M
FCF Per Share	1.99

Full Cash Flow Statement

Margins

Gross margin is 46.18%, with operating and profit margins of 8.91% and 4.59%.

Gross Margin	46.18%
Operating Margin	8.91%
Pretax Margin	6.89%
Profit Margin	4.59%
EBITDA Margin	14.25%
EBIT Margin	8.91%
FCF Margin	13.79%

Dividends & Yields

Eurobio Scientific Société anonyme does not appear to pay any dividends at this time.

Dividend Per Share	n/a
Dividend Yield	n/a
Dividend Growth (YoY)	n/a
Years of Dividend Growth	n/a
Payout Ratio	n/a
Buyback Yield	-8.96%
Shareholder Yield	-8.96%
Earnings Yield	2.33%
FCF Yield	7.70%

Stock Splits

The last stock split was on September 1, 2017. It was a reverse split with a ratio of 0.05.

Last Split Date	Sep 1, 2017
Split Type	Reverse
Split Ratio	0.05

Scores

Altman Z-Score	n/a
Piotroski F-Score	n/a